Four more firms object to OKX-ICE tokenized stock plan, total reaches 26
Four further companies, among them IBM, Oracle, Intel and IonQ, have objected to tokenized versions of their shares on the OKX-ICE venue, lifting the reported count to 26. The venue is run by Intercontinental Exchange and OKX, and the objections come as SEC issuer-consent rules face scrutiny.
Four new names added to the list
A revised public notice from the tokenized stock venue, dated October, now counts 26 companies that have objected to tokenized versions of their shares trading there, according to crypto.news. That is four more than the 22 objectors that Unchained reported earlier.
The additions are IBM, IonQ, Oracle and Intel, which occupy the final places on the notice's list. None of the four appeared in Unchained's earlier coverage. The wider list also features Microsoft, Alphabet, Goldman Sachs, Broadcom, Verizon, Wells Fargo, Arm Holdings and Intuit.
Companies and the tokenization model
Intel is a semiconductor and electrical company headquartered in Santa Clara, established in 1968. IBM is a software and IT consulting firm based in Armonk, founded in 1911. Tokenization represents an asset as a tradable entry on a blockchain.
The objections target OKX-ICE's plan to offer tokenized stock, blockchain representations of shares in these companies, without the consent of the issuers.
Risk warnings repeated in the notice
The revised notice repeats its risk disclosures. Among them, the access-token contract received no external audit, upgrades bypass a timelock, and SIPC protection for self-custodied tokens remains uncertain.
Regulatory backdrop and open points
The objections surface while SEC issuer-consent rules are under scrutiny, a question that goes to whether companies can be listed in tokenized form without their approval. The figures rest on a single outlet, crypto.news, which reported on the revised notice.
Open questions
- Will the SEC's issuer-consent rules be changed or clarified in light of these objections?
- Will the number of objecting companies rise further?
- How will the venue respond to the risk warnings it has restated?